A new target for differentiation therapy in AML

Peilin Ma, Weihua Song, Jay Hess

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.

Original languageEnglish (US)
JournalCell Research
DOIs
StateAccepted/In press - Nov 11 2016

Fingerprint

Acute Myeloid Leukemia
Epigenomics
Therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

A new target for differentiation therapy in AML. / Ma, Peilin; Song, Weihua; Hess, Jay.

In: Cell Research, 11.11.2016.

Research output: Contribution to journalArticle

@article{79be315d5ee0446099844c8c9926f046,
title = "A new target for differentiation therapy in AML",
abstract = "Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.",
author = "Peilin Ma and Weihua Song and Jay Hess",
year = "2016",
month = "11",
day = "11",
doi = "10.1038/cr.2016.130",
language = "English (US)",
journal = "Cell Research",
issn = "1001-0602",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A new target for differentiation therapy in AML

AU - Ma, Peilin

AU - Song, Weihua

AU - Hess, Jay

PY - 2016/11/11

Y1 - 2016/11/11

N2 - Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.

AB - Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84994777400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994777400&partnerID=8YFLogxK

U2 - 10.1038/cr.2016.130

DO - 10.1038/cr.2016.130

M3 - Article

C2 - 27834347

AN - SCOPUS:84994777400

JO - Cell Research

JF - Cell Research

SN - 1001-0602

ER -